Predictive Oncology Inc Stock price
Is Predictive Oncology Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Predictive Oncology Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a Predictive Oncology Inc forecast:
Analyst Opinions
6 Analysts have issued a Predictive Oncology Inc forecast:
Don't miss a Thing! We will send you all news about Predictive Oncology Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
| Head office | United States |
| CEO | Mr. Vennare |
| Employees | 24 |
| Founded | 2002 |
| Website | predictive-oncology.com |


